{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:41:12Z","timestamp":1774906872705,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1680,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1468-1293.2010.00906.x","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T01:28:21Z","timestamp":1296005301000},"page":"453-462","source":"Crossref","is-referenced-by-count":22,"title":["Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials"],"prefix":"10.1111","volume":"12","author":[{"given":"T","family":"Sivakumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OJ","family":"Mechanic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"Fehmie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BT","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB1|cit1","first-page":"126","article-title":"Disorders of body fat distribution in HIV-1-infected patients","volume":"11","author":"Moreno","year":"2009","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB2|cit2","first-page":"3","article-title":"Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy","volume":"9","author":"Mallon","year":"2007","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB3|cit3","first-page":"999","article-title":"Long-term complications of antiretroviral therapy","volume":"61","author":"Waters","year":"2007","journal-title":"lipoatrophy"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB4|cit4","first-page":"443","article-title":"Lipodystrophy in the patient with HIV","volume":"28","author":"Peterson","year":"2008","journal-title":"social, psychological, and treatment considerations"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/apc.2008.0067","article-title":"Treatment options for HIV-associated central fat accumulation","volume":"23","author":"Cofrancesco","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11102-008-0092-8","article-title":"GH\/GHRH axis in HIV lipodystrophy","volume":"12","author":"Stanley","year":"2009","journal-title":"Pituitary"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0b013e3280adc91e","article-title":"The role of adipokines in relation to HIV lipodystrophy","volume":"21","author":"Sweeney","year":"2007","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.86.2.504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB9|cit9","first-page":"286","article-title":"Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome","volume":"45","author":"Grunfeld","year":"2007","journal-title":"12 week induction and 24-week maintenance therapy"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archpedi.160.3.263","article-title":"Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature","volume":"160","author":"Lee","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0b013e32833b6bc7","article-title":"The diagnosis and treatment of growth hormone deficiency in adults","volume":"17","author":"Clemmons","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB12|cit12","unstructured":"Higgins J Green S http:\/\/www.cochrane-handbook.org"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","article-title":"A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation","volume":"19","author":"Falutz","year":"2005","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0b013e32830a5058","article-title":"Long-term safety and effects of Tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation","volume":"22","author":"Falutz","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB16|cit16","first-page":"311","article-title":"Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation","volume":"53","author":"Falutz","year":"2010","journal-title":"a randomized placebo-controlled trial with a safety extension"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB17|cit17","first-page":"509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation","volume":"300","author":"Lo","year":"2008","journal-title":"a randomized controlled trial"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB18|cit18","first-page":"781","article-title":"GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy","volume":"153","author":"Luzi","year":"2005","journal-title":"a randomized placebo-controlled study"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.1152\/ajpendo.00335.2003","article-title":"Metabolic regulation of growth hormone by free fatty acids, somatostatin and ghrelin in HIV-lipodystrophy","volume":"286","author":"Koutkia","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals","volume":"79","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/108729102760330254","article-title":"Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients","volume":"16","author":"Oette","year":"2002","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB23|cit23","first-page":"210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy","volume":"292","author":"Koutkia","year":"2004","journal-title":"a randomized controlled trial"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/507333","article-title":"Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy","volume":"43","author":"Wohl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB25|cit25","first-page":"67","article-title":"Effect of pioglitazone on HIV-1-related lipodystrophy","volume":"13","author":"Slama","year":"2008","journal-title":"a randomized double-blind placebo-controlled trial (ANRS 113)"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-125-11-199612010-00001","article-title":"Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Waters","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1468-1293.2010.00906.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.qai.0000243108.26136.66","article-title":"Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum","volume":"43","author":"Kotler","year":"2006","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2010.00906.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1293.2010.00906.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T02:07:04Z","timestamp":1637201224000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2010.00906.x"}},"subtitle":["Growth hormone axis treatments for lipodystrophy"],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2010.00906.x","relation":{},"ISSN":["1464-2662"],"issn-type":[{"value":"1464-2662","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}